Bayer AG
XETRA:BAYN
Bayer AG
EPS (Diluted)
Bayer AG
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
EPS (Diluted)
-€2
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
EPS (Diluted)
$0
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
EPS (Diluted)
€6
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
MPH Health Care AG
XETRA:93M1
|
EPS (Diluted)
€6
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
EPS (Diluted)
€1
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
EPS (Diluted)
€1
|
CAGR 3-Years
-10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's EPS (Diluted)?
EPS (Diluted)
-3
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's EPS (Diluted) amounts to -3 EUR.
What is Bayer AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
35%
The average annual EPS (Diluted) growth rates for Bayer AG have been 35% over the past three years .